Re: ZHCLF trades on the OTC

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

ryau1135

Rank: Mail Room [?]

Points: 56 [?]

Votes: 3 Score: 4.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: ZHCLF trades on the OTC

in response to

ZHCLF trades on the OTC

noretreat

posted on Jan 17, 2021 02:22AM

So if Zenith decides to do another private placement, how does that affect ZHCLF? If PP shares are offered at $1.60USD - $2.00USD, wouldn't they just buy all they could on the US OTC under that price? Current price there is around $0.36-$0.50.